Incidental Finding of a PSMA-Positive Pancreatic Cancer in a Patient Suffering from a Metastasized PSMA-Positive Prostate Cancer
Open Access
- 15 January 2021
- journal article
- editorial
- Published by MDPI AG in Diagnostics
- Vol. 11 (1) , 129
Abstract
An 82-year-old man suffering from prostate cancer that was scheduled for a radioreceptor-ligand therapy (RLT) presented with jaundice to our service. An abdominal ultrasound (US) revealed obstructive extrahepatic cholestasis due to a solid lesion located in the uncinate process of the pancreas. The Prostate Specific Membrane Antigen (PSMA) PET/CT prior to RLT showed multilocular PSMA positive tumor lesions in the lymph nodes, the lung and the pancreas. On request of the cancer board, an Endoscopic Ultrasound (EUS)-guided Fine-Needle Aspiration (FNA) of the pancreatic mass was performed revealing invasive pancreatic ductal adenocarcinoma incompatible with a prostate cancer metastasis leading to the diagnosis of a PSMA positive pancreatic ductal adenocarcinoma.Keywords
This publication has 10 references indexed in Scilit:
- Comparison of Prostate-Specific Membrane Antigen PET/CT and Contrast-Enhanced Magnetic Resonance Imaging in Follow-up Assessment of Juvenile Nasal Angiofibroma—A Novel Pilot StudyClinical Nuclear Medicine, 2020
- Peritumoral/vascular expression of PSMA as a diagnostic marker in hepatic lesionsDiagnostic Pathology, 2020
- PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2020
- Causes of misdiagnoses by thyroid fine-needle aspiration cytology (FNAC): our experience and a systematic reviewDiagnostic Pathology, 2020
- Expression of Prostate-Specific Membrane Antigen in Tumor-Associated Vasculature Predicts Poor Prognosis in Hepatocellular CarcinomaClinical and Translational Gastroenterology, 2019
- 68Ga-Labeled Prostate-Specific Membrane Antigen Is a Novel PET/CT Tracer for Imaging of Hepatocellular Carcinoma: A Prospective Pilot StudyJournal of Nuclear Medicine, 2018
- Incidental Detection of Hepatocellular Carcinoma on 68Ga-Labeled Prostate-Specific Membrane Antigen PET/CTClinical Nuclear Medicine, 2017
- Imaging of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-HBED-CC-PSMA PET/CTClinical Nuclear Medicine, 2017
- Prostate-specific membrane antigen as a marker of pancreatic cancer cellsMedical Oncology, 2014
- Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.1999